We are delighted to present the latest addition to our laboratory: the Olink Signature Q100. This state-of-the-art benchtop solution enables us to perform multiplex protein quantification and to enhance our proteomics portfolio.
The technology behind the instrument is a Proximity Extension Assay (PEA) in a DNA-coupled format. The advantage of this technology is not only the exceptional specificity and sensitivity but also the minimal sample volumes needed to conduct the analysis.
After completing a comprehensive and passed training on Olink Target 48 and Target 96 we are listed as service provider for Olink. Our certified personnel ensure the highest standards of data quality and reliability.
At Krems Bioanalytics, the Olink platform broadens our immunogenicity testing portfolio by enabling sensitive cytokine profiling in cell-based assays and clinical samples— supporting the detection of immune activation and immune-related effects of therapeutic candidates.
The addition of the Olink platform underscores our commitment to innovation and excellence. For inquiries or further information, please don’t hesitate to reach out to us.
